6 Breast Changes You Should Never Ignore

For Breast Cancer Awareness Month, Dr. Thaïs Aliabadi shares her own breast cancer story and the lessons she wants every woman to take from it.

Dr. A explains how an abnormal breast biopsy led her to calculate her lifetime breast cancer risk, why she continued pushing for a preventative double mastectomy despite being repeatedly reassured that she was fine, and the shocking pathology result that revealed breast cancer after surgery.

She also breaks down six breast changes women should take seriously, including new or persistent breast lumps, skin dimpling, nipple changes, discharge, persistent flaky or scaly skin and changes in the appearance of the breast skin.

Dr. A explains the difference between traditional monthly self-exams and breast awareness, why knowing what is normal for your body matters, and when a breast change should prompt a call to your doctor.

Plus, we discuss dense breasts, mammograms and ultrasounds, family history, lifetime breast cancer risk, genetic testing, polygenic risk scores and why being young or having no family history does not mean a breast change should be dismissed.

This episode is about knowing your risk, noticing changes and becoming your own health advocate.

‍‍

Sponsors

OSEA Malibu: The episode features OSEA Malibu’s Undaria Algae Body Oil, a seaweed-infused body oil designed to moisturize skin and promote a healthy-looking glow. Use code CMD for 10% off your first order.

Gusto: Featured in a sponsored segment about simplifying payroll, tax filings, HR, and employee benefits for small businesses. The episode promotes three months of free payroll for eligible new customers.

Peloton: Featured in a sponsored segment introducing the Tread Flex treadmill and discussing accessible running, walking, hiking, and at-home fitness.

David Protein: Featured in a sponsored segment highlighting the brand's high-protein bars, including its Gold and Bronze product lines. The episode promotes a buy-four-cartons-get-the-fifth-free offer.

‍

‍

‍What You’ll Learn

• How Dr. Thaïs Aliabadi discovered that her lifetime breast cancer risk was significantly higher than expected, despite having no family history or known major genetic mutations.
• Why atypical lobular hyperplasia can increase breast cancer risk and why understanding biopsy results matters when evaluating your personal risk.
• How Dr. Aliabadi's experience with preventive mastectomy ultimately led to an unexpected breast cancer diagnosis.
• Why breast cancer concerns can be dismissed in healthcare settings and how patients can advocate for further evaluation when something does not feel right.
• The six breast changes that warrant medical attention: a new or persistent lump, skin dimpling or other skin changes, nipple discharge, newly inverted nipples, persistent crusting or scaling of the nipple, and unusual redness or discoloration.
• The difference between routine self-breast examinations and breast awareness, including why it is important to recognize what is normal for your own body.
• How family history, breast density, previous biopsies, hormonal history, and other factors can contribute to an individual's breast cancer risk assessment.
• What the Tyrer-Cuzick risk assessment tool evaluates and how a lifetime risk estimate can help inform conversations about screening.
• Why dense breast tissue can both increase breast cancer risk and make abnormalities more difficult to identify on a mammogram.
• How 3D mammography, breast ultrasound, and breast MRI may be used in screening plans, depending on individual risk and clinical guidance.
• What genetic testing can reveal about inherited breast cancer risk, including mutations in genes such as BRCA.
• What polygenic risk scores measure and how numerous genetic variants may contribute to breast cancer risk even when a person does not have a major known genetic mutation.
• Why breast implants do not eliminate the need for appropriate breast awareness and screening.
• Why new or persistent breast changes should be evaluated by a healthcare professional, even in younger women or those without a family history of breast cancer.

‍Key Takeaways

• Breast cancer risk is not determined by family history alone. Dr. Aliabadi's experience demonstrates why a lack of known family history or a major genetic mutation does not eliminate the possibility of developing breast cancer. Personal risk assessment should consider multiple factors, including previous breast biopsies, breast density, and relevant medical and family history.
• Know what is normal for your breasts. Breast texture, tenderness, and fullness can change with menstrual cycles and hormonal fluctuations. Becoming familiar with your usual breast appearance and feel can help you recognize new or persistent changes that deserve medical attention.
• Recognize the six breast changes discussed in the episode. These include a new or persistent lump, skin dimpling or other visible skin changes, nipple discharge, newly inverted nipples, persistent crusting or scaling of the nipple, and unusual skin discoloration. These changes do not automatically indicate cancer, but they should be evaluated by a healthcare professional.
• Dense breast tissue can complicate cancer detection. Dense breasts contain more glandular and connective tissue relative to fat. Because both dense tissue and many breast cancers appear white on a mammogram, abnormalities can be harder to see. Breast density is also an independent risk factor, making it important to discuss appropriate screening options with a healthcare provider.
• Personalized risk assessment can help inform screening decisions. Tools such as the Tyrer-Cuzick model use information about family history and other risk factors to estimate lifetime breast cancer risk. Screening recommendations can vary depending on a person's risk profile, age, medical history, and applicable clinical guidelines.
• Genetic risk involves more than a single mutation. Genetic testing can identify inherited mutations associated with increased breast cancer risk. Polygenic risk scores assess the combined contribution of numerous genetic variants. These approaches provide different types of information and may help clinicians develop a more complete picture of risk when appropriate.
• Preventive decisions can involve difficult trade-offs. Dr. Aliabadi shares the physical challenges, uncertainty, and emotional weight involved in deciding to undergo preventive surgery. Her story highlights the importance of informed decision-making, individualized medical guidance, and having one's concerns taken seriously.
• Do not assume you are too young for a breast abnormality to matter. Although most breast changes are not cancerous, symptoms should not be dismissed based on age alone. Persistent or concerning changes warrant timely evaluation, and seeking another medical opinion may be appropriate when concerns remain unresolved.
• Patient advocacy is an important part of healthcare. Understanding your medical history, asking questions, requesting clarification about screening options, and seeking further evaluation when necessary can help you participate more actively in decisions about your health.
• Early detection and risk reduction are distinct but complementary goals. No screening strategy can prevent every breast cancer diagnosis. However, understanding personal risk, following an appropriate screening plan, and responding to new symptoms can support earlier detection and more informed care.

‍